XT
TRAW icon

XTX Topco’s Traws Pharma TRAW Stock Holding History

XTX Topco’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Buy
+18,092
New +$24.9K ﹤0.01% 3960
2026
Q1 		– Sell
-42,210
Closed -$47.7K – 4495
2025
Q4 		$47.7K Buy
42,210
+31,502
+294% +$70.1K ﹤0.01% 2847
2025
Q3 		$19.8K Buy
+10,708
New +$17.5K ﹤0.01% 2332

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

XTX Topco's TRAW Position: Q2 2026 in Review

XTX Topco opened a new position in Traws Pharma (TRAW) in Q2 2026: 18,092 shares worth $15.3K. The stake represents ﹤0.01% of the portfolio and ranks #3960 among its holdings. This is a return to the name: XTX Topco previously reported a position in TRAW as recently as Q4 2025.

XTX Topco first reported a position in TRAW in Q3 2025 and has held it in 3 quarters since. The position peaked at $47.7K in Q4 2025. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • XTX Topco held 18,092 shares of Traws Pharma worth $15.3K as of Q2 2026.
  • Traws Pharma was a new XTX Topco position in Q2 2026.
  • Traws Pharma made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3960 holding.
  • XTX Topco first reported a position in Traws Pharma in Q3 2025 and has held it in 3 quarters since.
  • XTX Topco's Traws Pharma position peaked at $47.7K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.